STADA Arzneimittel Articles
Stada Arz takes top active ingredients in AOK tender round
12 February 2013
Good start to 2013 for Stada Arz in German tender process
27 January 2013
Stada Arz sells two Russian production facilities
16 August 2012
Stada Arz first-half 2012 sales rise 7%
8 August 2012
Stada Arz reports solid start to 2012
10 May 2012
Stada Arz viewing optimization of Russian operations
23 April 2012
STADA Arz sets up subsidiary in Australia
27 March 2012
STADA pulls out of part of Grunenthal deal
4 January 2012
STADA to buy Spirig generics business for $109 million; posts 9-month loss due to Serbian difficulties
11 November 2011
Ipsen sells North American rights for Apokyn to Britannia Pharma
3 November 2011
Germany’s Stada Arz warns of risk of Serbian default
22 September 2011
Stada Arz and Richter link up to develop and market two biosimilars: rituximab and trastuzumab
1 September 2011
Showing 1-21 of 21 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
